CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS (UNAUDITED) - EUR (€) € in Thousands	3 Months Ended
	Mar. 31, 2021	Mar. 31, 2020
Revenue
Research and development services	€ 3	€ 17
Grants	131	255
Total revenues	134	272
Expenses
Research and development	254	322
General and administrative	291	325
Total expenses	545	647
Operating loss	(411)	(375)
Interest expense	685	675
Other expense	122	106
Loss before income tax provision	(1,218)	(1,156)
Income tax provision	(28)	(8)
Net loss	(1,246)	(1,164)
Other Comprehensive Loss
Foreign currency translation adjustment	(8)	7
Comprehensive loss	€ (1,254)	€ (1,157)
Basic and diluted earnings per share	€ (0.00)	€ (0.00)
Weighted-average shares outstanding, basic and diluted	303,757,622	303,757,622